Cancer Therapy is a Fight for Time. Quality Time with Loved Ones is Precious. Time Matters.
ANKTIVA® is the first FDA-approved drug for non-muscle invasive bladder cancer CIS that proliferates natural killer cells, T cells and memory T cells for a durable response.
ANKTIVA is a Potent Immunostimulant that Unlocks Anti-tumor Activity and Unleashes Durable, Complete Responses.
ANKTIVA uniquely stimulates the body’s natural immune system by proliferating and activating natural killer cells, as well as cytotoxic and memory T cells to drive long-term immune memory and durable responses.
Months
of duration of response)
Getting Started with ANKTIVA for Patients
A patient-friendly overview of how ANKTIVA plus BCG work together, as well as what patients should expect before and after treatment
Patient Stories
Read about patients who participated in the clinical trials for ANKTIVA
Irv’s Journey
He was first diagnosed with bladder cancer in 2016, when on Thanksgiving day, he had several concerning symptoms including blood in his urine. Several tumors on the interior surface of his bladder were removed by his local urologist, who treated him with BCG. Unfortunately, he failed to respond and the tumors came back. He was afraid he was going to lose his bladder.
Wayne’s Journey
Wayne has lived a rich life with his wife, two daughters, and three grandchildren. He describes himself as someone who “just likes people”. When he was first told, “you might have a tumor in your bladder”, he became very concerned, especially when he learned his first treatment with BCG wasn’t working. Wayne feels lucky that a friend told him about a clinical trial for patients like himself who were not cured by BCG alone.
ANKTIVA Resources
Information for ANKTIVA
ANKTIVA: Efficacy & Safety
A clinical resource highlighting key efficacy and safety information about ANKTIVA (nogapendekin alfa inbakicept-pmln)
ANKTIVA: Mechanism of Action
A description of how BCG and ANKTIVA work together in NMIBC CIS
ANKTIVA: How to Order
A step-by-step guide on how to order ANKTIVA, including product codes
Physicians' Journey
Listen to the physicians' journey with their patients using ANKTIVA.
ANKTIVA is a Novel Treatment for NMIBC CIS Patients Unresponsive to BCG
For more information, please call 1-877-ANKTIVA
